Oral bisphosphonate medications like alendronate (Fosamax), may not be absorbed well by the body when they’re taken with ...
India's pharmaceutical market rose 7.3% year-on-year in September to ₹20,886 crore, driven by robust growth in antidiabetic, ...
In patients with type 2 diabetes, GLP-1 use was not associated with higher risks for most serious gastrointestinal or ...
By Dennis Thompson HealthDay ReporterMONDAY, Oct. 6, 2025 (HealthDay News) — An approved pill for Alzheimer’s disease might ...
India's pharmaceutical market demonstrated robust growth, climbing 8.1% in August, fueled by chronic treatments like cardiac and anti-diabetic drugs. Respiratory and cancer medications also saw strong ...
Type 2 diabetes medications, such as sulfonylureas, have been a mainstay of treating the disease since they came on the market in the early 1950s. However, although they are one of the most common ...
The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has opined that Novo Nordisk ...
Biomea Fusion shares spiked on positive 52-week Phase II data for icovamenib in type 2 diabetes. Read why I rate BMEA stock a ...
Sulphonylureas, among other drugs for type 2 diabetes, have been a key treatment for the disease since their introduction in the early 1950s. However ...
Verywell Health on MSN
How Long Does It Take for Berberine to Lower Your Blood Sugar?
Berberine can improve blood sugar control. Learn the role of berberine in lowering blood sugar levels and how long it takes ...
Treatment with GLP-1 RAs was linked to decreased risks for all-cause mortality and MACE in patients with psoriasis when compared with other antidiabetic or obesity drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback